FAST NEWS: Structure Therapeutics Leaps in U.S. Trading Debut
The latest: Innovative drug developer Structure Therapeutics Inc. (GPCR.US) made its IPO trading debut last Friday, becoming the first major U.S. listing by a Chinese company this year.Looking up: The company…
Structure Therapeutics Hopes to Wow Investors With Cutting-Edge Drug Tech
The maker of G-protein-coupled receptor (GPCR) drugs will raise more than $100 million in its IPO this week, making it the first major U.S. listing by a Chinese company this…
